Opposite regulation of cAMP concentration in the quail oviduct and the mouse uterus by tamoxifen. Correlation with estrogen-antagonist and estrogen-agonist activity
- 31 March 1992
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 41 (3-8), 571-577
- https://doi.org/10.1016/0960-0760(92)90386-w
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; Correlations with cytotoxicityBiochemical Pharmacology, 1990
- Effects of Tamoxifen, Tamoxifen Metabolites, and Nafoxidine on Adenosine 3′,5′-Monophosphate Phosphodiesterase: Correlations with Growth Inhibitory Activities but not Estrogen Receptor Affinities*Endocrinology, 1989
- Metabolism of steroid-modifying anticancer agentsPharmacology & Therapeutics, 1988
- Pharmacodynamic and biological effects of anti-estrogens in different modelsJournal of Steroid Biochemistry, 1988
- Effect of Estrogen on Adenosine 3′,5′,Cyclic Monophosphate in Quail Oviduct: Possible Involvement in Estradiol-Activated Growth*Endocrinology, 1988
- Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesteraseBiochemical and Biophysical Research Communications, 1984
- Identification and biological activity of tamoxifen metabolites in human serumBiochemical Pharmacology, 1983
- Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycleEuropean Journal of Cancer and Clinical Oncology, 1983
- The biology and physiology of ‘Nolvadex’ (tamoxifen) in the treatment of breast cancerBreast Cancer Research and Treatment, 1982
- A MONOHYDROXYLATED METABOLITE OF TAMOXIFEN WITH POTENT ANTIOESTROGENIC ACTIVITYJournal of Endocrinology, 1977